seen from Argentina
seen from Colombia
seen from Malaysia
seen from United States
seen from Argentina
seen from United States
seen from United States
seen from Palestinian Territories
seen from United States
seen from United States
seen from Nicaragua
seen from United States
seen from Netherlands
seen from Tunisia
seen from China
seen from United States
seen from United States
seen from United States
seen from France
seen from United States
Genetic testing detects BRCA gene mutations in individuals with high risk of breast cancer which helps the patient in taking informed medical decisions.
#BRCA #BRCA1andBRCA2genes #genetictesting #Breastcancer
Connect Today - #GENES2ME
18001214030
Knowledge of BRCA mutation status can help estimate the chemotherapy response and may influence decisions pertaining to specific cancer therapy in BRCA mutation carriers.
#BRCA #BRCA1andBRCA2genes #genetictesting #Breastcancer
Connect Today - #GENES2ME
18001214030
Genetic testing detects the presence of mutated BRCA1 and BRCA2 genes by scanning the genome of Individuals. BRCA1 and BRCA2 genes using NGS technologies.
BRCA1 gene test is an utmost requirement for the detection of ovarian and breast cancer. BRCA1 test is usually performed in combination with BRCA2 for the diagnosis of breast cancer. Mutation in either BRCA1 or BRCA2 gene can put an individual at risk for breast cancer development. Usually, the BRCA1 gene functions as a tumour suppressor gene and plays a significant role in the DNA repair mechanism. BRCA1 test should be done at an early stage to design efficient protocols for breast or ovarian cancer treatment.
